The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
The FDA has approved obinutuzumab for the treatment of adults with active lupus nephritis who are receiving standard therapy, ...
The Lupus Foundation of America (LFA) and its funded researchers will unveil the latest advances in patient-centered research ...
Pharmaceutical Technology on MSN
FDA approves Roche’s Gazyva for lupus nephritis
The US Food and Drug Administration (FDA) has granted approval for Roche's Gazyva/ Gazyvaro (obinutuzumab) to treat adult ...
With the lupus treatment landscape poised for a shake-up, Roche is hitting t | Early Monday, Roche announced that the FDA ...
Lupus continues to carry a heavy burden despite advances in immunosuppressive therapy warranting complementary care ...
As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were ...
Actress and singer Selena Gomez has been open about her experience living with lupus. Since 2015, Gomez has documented on ...
Lupus & You is a free educational series where people with lupus and their family and friends can learn more about the latest in lupus research and managing the disease. Our recent Lupus & You: ...
Doctors advise you to approach HRT with caution if you have lupus. HRT may increase the risk of flares or blood clots in some people. There are factors that you need to consider if you have lupus and ...
The FDA has approved Genentech’s Gazyva (obinutuzumab) for the treatment of lupus nephritis in adults, according to a news release published today. Gazyva is the first and only anti-CD20 monoclonal ...
Investing.com -- The U.S. Food and Drug Administration (FDA) has approved Roche Holding AG’s (SIX:RO) Gazyva/Gazyvaro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback